Literature DB >> 8320991

Coronary bypass grafting in the elderly. Single versus bilateral internal mammary artery grafts.

D L Galbut1, E A Traad, M J Dorman, P L DeWitt, P B Larsen, P A Kurlansky, R G Carrillo, T O Gentsch, G Ebra.   

Abstract

A surgical experience between October 1983 and December 1990, with 1467 consecutive patients 65 years of age and over, was used to compare patients receiving single internal mammary artery grafts (n = 736) with those receiving bilateral internal mammary artery grafts (n = 731). The mean age in the single-graft group was 73.2 years and 70.9 years in the bilateral-graft group (p < 0.001). Various clinical parameters were analyzed that revealed that the single-graft group had more women and more patients with unstable angina, a history of previous myocardial infarction, and emergency surgery (p < 0.05). There was no significant difference in cigarette smoking, hypertension, diabetes mellitus, hyperlipidemia, triple vessel coronary artery disease, left main coronary artery stenosis, or left ventricular function between the two groups. Hospital mortality for the single-graft group was 6.4% (47 patients) and 3.1% (23 patients) for the bilateral-graft group (p < 0.004). No significant difference was observed between the groups in the rate of reoperation for bleeding, sternal infection, respiratory failure, stroke, or perioperative infarction. Follow-up was obtained in 663 hospital survivors (96.4%) in the single-graft group and in 691 (97.7%) in the bilateral-graft group. Mean follow-up in the single-graft group was 42.5 months (range, 1 to 92.4 months) and 43.0 months (range, 1 to 90.3 months) in the bilateral-graft group. In the single-graft group, survival was 60.7% +/- 4.8% (+/- standard error of the mean) at 8 years (60 patients at risk); it was 67.9% +/- 8.1% (18 patients at risk) for the bilateral-graft group (p < 0.028). This comparative study demonstrates that bilateral internal mammary artery grafting can be accomplished in elderly patients with low operative risk and hospital morbidity. Moreover, patients in both groups had a reduction in cardiac events and significant functional improvement.

Entities:  

Mesh:

Year:  1993        PMID: 8320991

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Extended use of bilateral internal thoracic arteries for coronary artery bypass grafting in the elderly.

Authors:  Takashi Hirotani; Tsukasa Nakamichi; Mamoru Munakata; Shigeyuki Takeuchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-10

2.  Suitability and durability of multiple internal thoracic artery coronary artery bypasses.

Authors:  J W Jones; S E Schmidt; R Miller; C Nahas; A C Beall
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

3.  Early and late outcome of skeletonised bilateral internal mammary arteries anastomosed to the left coronary system.

Authors:  M Bonacchi; F Battaglia; E Prifti; M Leacche; N S Nathan; G Sani; G Popoff
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

Review 4.  [Arterial myocardial revascularization in the 9th decade of life. Personal results and review of the literature].

Authors:  A Mortasawi; I C Ennker; A Albert; U Rosendahl; F Dalladaku; T Alexander; J Ennker
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

5.  Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass.

Authors:  Zachary N Kon; Emile N Brown; Richard Tran; Ashish Joshi; Barry Reicher; Michael C Grant; Seeta Kallam; Nicholas Burris; Ingrid Connerney; David Zimrin; Robert S Poston
Journal:  J Thorac Cardiovasc Surg       Date:  2007-12-26       Impact factor: 5.209

6.  Lessons learned from the use of 1,977 in-situ bilateral internal mammary arteries: a retrospective study.

Authors:  Siamak Mohammadi; Francois Dagenais; Pierre Voisine; Eric Dumont; Richard Baillot; Daniel Doyle; Eric Charbonneau; Dimitri Kalavrouziotis
Journal:  J Cardiothorac Surg       Date:  2014-09-20       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.